Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
N/A
-8,676 Closed
0 $0
Q1 2021

May 12, 2021

BUY
N/A
1,047 Added 13.72%
8,676 $25,000
Q4 2020

Feb 11, 2021

SELL
N/A
-25,341 Reduced 76.86%
7,629 $16,000
Q3 2020

Nov 12, 2020

SELL
N/A
-5,296 Reduced 13.84%
32,970 $204,000
Q2 2020

Jul 31, 2020

BUY
N/A
38,266 New
38,266 $246,000
Q3 2019

Nov 14, 2019

SELL
N/A
-1,395 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
N/A
425 Added 43.81%
1,395 $11,000
Q1 2019

May 14, 2019

SELL
N/A
-2,120 Reduced 68.61%
970 $8,000
Q4 2018

Feb 14, 2019

BUY
N/A
3,090 New
3,090 $14,000

About Catabasis Pharmaceuticals, Inc.


  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.